Recursion Pharmaceuticals, Inc. RXRX Deferred Taxes
Deferred Taxes at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxLiabilitiesNet.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s deferred taxes.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s deferred taxes?
- Recursion Pharmaceuticals, Inc. (RXRX) reported deferred taxes of $18.28M in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s deferred taxes changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s deferred taxes decreased by 18.5% year-over-year, from $22.44M to $18.28M.
- What does deferred taxes mean?
- This represents the net amount of income taxes that will be payable in future periods due to temporary differences between the carrying amount of assets and liabilities for financial reporting and their tax bases. It reflects the long-term tax impact of accounting choices and depreciation schedules. Investors use this to understand future tax obligations and the impact of tax timing on cash flow.